1,937 research outputs found
Prediction of preterm birth with and without preeclampsia using mid-pregnancy immune and growth-related molecular factors and maternal characteristics.
OBJECTIVE:To evaluate if mid-pregnancy immune and growth-related molecular factors predict preterm birth (PTB) with and without (±) preeclampsia. STUDY DESIGN:Included were 400 women with singleton deliveries in California in 2009-2010 (200 PTB and 200 term) divided into training and testing samples at a 2:1 ratio. Sixty-three markers were tested in 15-20 serum samples using multiplex technology. Linear discriminate analysis was used to create a discriminate function. Model performance was assessed using area under the receiver operating characteristic curve (AUC). RESULTS:Twenty-five serum biomarkers along with maternal age <34 years and poverty status identified >80% of women with PTB ± preeclampsia with best performance in women with preterm preeclampsia (AUC = 0.889, 95% confidence interval (0.822-0.959) training; 0.883 (0.804-0.963) testing). CONCLUSION:Together with maternal age and poverty status, mid-pregnancy immune and growth factors reliably identified most women who went on to have a PTB ± preeclampsia
The interaction studied via femtoscopy in p + Nb reactions at
We report on the first measurement of and correlations via
the femtoscopy method in p+Nb reactions at , studied with the High Acceptance Di-Electron Spectrometer
(HADES). By comparing the experimental correlation function to model
calculations, a source size for pairs of and a slightly
smaller value for of is extracted.
Using the geometrical extent of the particle emitting region, determined
experimentally with correlations as reference together with a source
function from a transport model, it is possible to study different sets of
scattering parameters. The correlation is proven sensitive to
predicted scattering length values from chiral effective field theory. We
demonstrate that the femtoscopy technique can be used as valid alternative to
the analysis of scattering data to study the hyperon-nucleon interaction.Comment: 12 pages, 11 figure
Genomic epidemiology and population structure of Neisseria gonorrhoeae from remote highly endemic Western Australian populations
Background: Neisseria gonorrhoeae causes gonorrhoea, the second most commonly notified sexually transmitted infection in Australia. One of the highest notification rates of gonorrhoea is found in the remote regions of Western Australia (WA). Unlike isolates from the major Australian population centres, the remote community isolates have low rates of antimicrobial resistance (AMR). Population structure and whole-genome comparison of 59 isolates from the Western Australian N. gonorrhoeae collection were used to investigate relatedness of isolates cultured in the metropolitan and remote areas. Core genome phylogeny, multilocus sequencing typing (MLST), N. gonorrhoeae multi-antigen sequence typing (NG-MAST) and N. gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) in addition to hierarchical clustering of sequences were used to characterize the isolates. Results: Population structure analysis of the 59 isolates together with 72 isolates from an international collection, revealed six population groups suggesting that N. gonorrhoeae is a weakly clonal species. Two distinct population groups, Aus1 and Aus2, represented 63% of WA isolates and were mostly composed of the remote community isolates that carried no chromosomal AMR genotypes. In contrast, the Western Australian metropolitan isolates were frequently multi-drug resistant and belonged to population groups found in the international database, suggesting international transmission of the isolates. Conclusions: Our study suggests that the population structure of N. gonorrhoeae is distinct between the communities in remote and metropolitan WA. Given the high rate of AMR in metropolitan regions, ongoing surveillance is essential to ensure the enduring efficacy of the empiric gonorrhoea treatment in remote WA
Shedding light on X17: community report
The workshop “Shedding light on X17” brings together scientists looking for the existence of a possible new light particle, often referred to as X17. This hypothetical particle can explain the resonant structure observed at ∼ 17 MeV in the invariant mass of electron-positron pairs, produced after excitation of nuclei such as 8Be and 4He by means of proton beams at the Atomki Laboratory in Debrecen. The purpose of the workshop is to discuss implications of this anomaly, in particular theoretical interpretations as well as present and future experiments aiming at confirming the result and/or at providing experimental evidence for its interpretation
Shedding light on X17: community report
The workshop “Shedding light on X17” brings together scientists looking for the existence of a possible new light particle, often referred to as X17. This hypothetical particle can explain the resonant structure observed at ∼ 17 MeV in the invariant mass of electron-positron pairs, produced after excitation of nuclei such as 8Be and 4He by means of proton beams at the Atomki Laboratory in Debrecen. The purpose of the workshop is to discuss implications of this anomaly, in particular theoretical interpretations as well as present and future experiments aiming at confirming the result and/or at providing experimental evidence for its interpretation
The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination.
Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide and is associated with high case fatality rates and serious life-long complications among survivors. Twelve serogroups are recognised, of which six (A, B, C, W, X and Y) are responsible for nearly all cases of invasive meningococcal disease (IMD). The incidence of IMD and responsible serogroups vary widely both geographically and over time. For the first time, effective vaccines against all these serogroups are available or nearing licensure. Over the past two decades, IMD incidence has been declining across most parts of the world through a combination of successful meningococcal immunisation programmes and secular trends. The introduction of meningococcal C conjugate vaccines in the early 2000s was associated with rapid declines in meningococcal C disease, whilst implementation of a meningococcal A conjugate vaccine across the African meningitis belt led to near-elimination of meningococcal A disease. Consequently, other serogroups have become more important causes of IMD. In particular, the emergence of a hypervirulent meningococcal group W clone has led many countries to shift from monovalent meningococcal C to quadrivalent ACWY conjugate vaccines in their national immunisation programmes. Additionally, the recent licensure of two protein-based, broad-spectrum meningococcal B vaccines finally provides protection against the most common group responsible for childhood IMD across Europe and Australia. This review describes global IMD epidemiology across each continent and trends over time, the serogroups responsible for IMD, the impact of meningococcal immunisation programmes and future needs to eliminate this devastating disease
- …
